805 related articles for article (PubMed ID: 23890065)
1. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance.
Zitvogel L; Galluzzi L; Smyth MJ; Kroemer G
Immunity; 2013 Jul; 39(1):74-88. PubMed ID: 23890065
[TBL] [Abstract][Full Text] [Related]
2. Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents.
Galluzzi L; Buqué A; Kepp O; Zitvogel L; Kroemer G
Cancer Cell; 2015 Dec; 28(6):690-714. PubMed ID: 26678337
[TBL] [Abstract][Full Text] [Related]
3. Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy.
Hannani D; Sistigu A; Kepp O; Galluzzi L; Kroemer G; Zitvogel L
Cancer J; 2011; 17(5):351-8. PubMed ID: 21952286
[TBL] [Abstract][Full Text] [Related]
4. Immune-mediated mechanisms influencing the efficacy of anticancer therapies.
Coffelt SB; de Visser KE
Trends Immunol; 2015 Apr; 36(4):198-216. PubMed ID: 25857662
[TBL] [Abstract][Full Text] [Related]
5. Putting the brakes on anticancer therapies: suppression of innate immune pathways by tumor-associated myeloid cells.
Jinushi M; Yagita H; Yoshiyama H; Tahara H
Trends Mol Med; 2013 Sep; 19(9):536-45. PubMed ID: 23810190
[TBL] [Abstract][Full Text] [Related]
6. Immunological aspects of cancer chemotherapy.
Zitvogel L; Apetoh L; Ghiringhelli F; Kroemer G
Nat Rev Immunol; 2008 Jan; 8(1):59-73. PubMed ID: 18097448
[TBL] [Abstract][Full Text] [Related]
7. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity.
Smyth MJ; Dunn GP; Schreiber RD
Adv Immunol; 2006; 90():1-50. PubMed ID: 16730260
[TBL] [Abstract][Full Text] [Related]
8. [Immunological aspects of anticancer chemotherapy].
Zitvogel L; Tesniere A; Apetoh L; Ghiringhelli F; Kroemer G
Bull Acad Natl Med; 2008 Oct; 192(7):1469-87; discussion 1487-9. PubMed ID: 19445369
[TBL] [Abstract][Full Text] [Related]
9. On the immunopharmacology of cancer chemotherapeutics.
Spreafico F
Behring Inst Mitt; 1984 May; (74):230-8. PubMed ID: 6541034
[TBL] [Abstract][Full Text] [Related]
10. Harnessing dendritic cells in cancer.
Apetoh L; Locher C; Ghiringhelli F; Kroemer G; Zitvogel L
Semin Immunol; 2011 Feb; 23(1):42-9. PubMed ID: 21295491
[TBL] [Abstract][Full Text] [Related]
11. Cancer therapy with trifunctional antibodies: linking innate and adaptive immunity.
Hess J; Ruf P; Lindhofer H
Future Oncol; 2012 Jan; 8(1):73-85. PubMed ID: 22149036
[TBL] [Abstract][Full Text] [Related]
12. [Effect of chemotherapy on anticancer immune effector cells].
Saijo N
Gan To Kagaku Ryoho; 1983 Mar; 10(3):699-707. PubMed ID: 6410999
[TBL] [Abstract][Full Text] [Related]
13. Immune cells as anti-cancer therapeutic targets and tools.
Johansson M; Tan T; de Visser KE; Coussens LM
J Cell Biochem; 2007 Jul; 101(4):918-26. PubMed ID: 17265430
[TBL] [Abstract][Full Text] [Related]
14. Innate immunity and cancer therapy.
Maruyama K; Selmani Z; Ishii H; Yamaguchi K
Int Immunopharmacol; 2011 Mar; 11(3):350-7. PubMed ID: 20955832
[TBL] [Abstract][Full Text] [Related]
15. Desirable cell death during anticancer chemotherapy.
Locher C; Conforti R; Aymeric L; Ma Y; Yamazaki T; Rusakiewicz S; Tesnière A; Ghiringhelli F; Apetoh L; Morel Y; Girard JP; Kroemer G; Zitvogel L
Ann N Y Acad Sci; 2010 Oct; 1209():99-108. PubMed ID: 20958322
[TBL] [Abstract][Full Text] [Related]
16. The inducers of immunogenic cell death for tumor immunotherapy.
Li X
Tumori; 2018; 104(1):1-8. PubMed ID: 28967094
[TBL] [Abstract][Full Text] [Related]
17. From cancer immunosurveillance to cancer immunotherapy.
Stagg J; Johnstone RW; Smyth MJ
Immunol Rev; 2007 Dec; 220():82-101. PubMed ID: 17979841
[TBL] [Abstract][Full Text] [Related]
18. Impact of myeloid cells on the efficacy of anticancer chemotherapy.
Senovilla L; Aranda F; Galluzzi L; Kroemer G
Curr Opin Immunol; 2014 Oct; 30():24-31. PubMed ID: 24950501
[TBL] [Abstract][Full Text] [Related]
19. [Augmentation of antitumor immunity in cancer chemotherapy].
Hosokawa M; Kobayashi H
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1402-6. PubMed ID: 1697151
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 21: combination strategies for cancer therapy.
Skak K; Kragh M; Hausman D; Smyth MJ; Sivakumar PV
Nat Rev Drug Discov; 2008 Mar; 7(3):231-40. PubMed ID: 18259184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
